Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

ClinicalTrials.gov ID: NCT02247531

Public ClinicalTrials.gov record NCT02247531. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 9:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Assess the Efficacy and Safety of Lampalizumab Administered Intravitreally to Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Study identification

NCT ID
NCT02247531
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
975 participants

Conditions and interventions

Interventions

  • Lampalizumab Drug
  • Sham Comparator Other

Drug · Other

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 5, 2014
Primary completion
Jan 22, 2018
Completion
Jan 22, 2018
Last update posted
Oct 14, 2019

2014 – 2018

United States locations

U.S. sites
67
U.S. states
28
U.S. cities
63
Facility City State ZIP Site status
Associated Retina Consultants Phoenix Arizona 85020
Retina Associates Southwest PC Tucson Arizona 85750
Retina Consultants of Orange County Fullerton California 92835
UCSD Shiley Eye Center La Jolla California 92093-0946
Jules Stein Eye Institute/ UCLA Los Angeles California 90095-7000
N CA Retina Vitreous Assoc Mountain View California 94040
Byers Eye Insitute at Stanford Palo Alto California 94303
Retina Consultants, San Diego Poway California 92064
University of California, Davis, Eye Center Sacramento California 95817
Retinal Consultants Med Group Sacramento California 95841
California Retina Consultants Santa Barbara California 93103
Bay Area Retina Associates Walnut Creek California 94598
University of Colorado Aurora Colorado 80045
Retina Consultants of Southern Colorado Springs Colorado 80909
Colorado Retina Associates, PC Golden Colorado 80401
New England Retina Associates Hamden Connecticut 06518
Retina Group of New England Waterford Connecticut 06385
Retina Group of Florida Fort Lauderdale Florida 33308
Retina Health Center Fort Myers Florida 33907
Bascom Palmer Eye Institute Naples Florida 34103
Retina Vitreous Assoc of FL St. Petersburg Florida 33711
Southern Vitreoretinal Assoc Tallahassee Florida 32308
University of South Florida Tampa Florida 33612
Emory University Atlanta Georgia 30329
Wolfe Eye Clinic West Des Moines Iowa 50266
Vitreo Retinal Consultants Wichita Kansas 67214
Paducah Retinal Center Paducah Kentucky 42001
The Retina Care Center Baltimore Maryland 21209
Wilmer Eye Institute Baltimore Maryland 21287
Retina Group of Washington Chevy Chase Maryland 20815
Retina Specialists Towson Maryland 21204
Mass Eye and Ear Infirmary Boston Massachusetts 02114
University of Michigan, Kellogg Eye Center Ann Arbor Michigan 48105
Kresge Eye Institute Detroit Michigan 48201-1423
Vitreoretinal Surgery Edina Minnesota 55435
Midwest Vision Research Foundation Chesterfield Missouri 63017
UNMC Truhlsen Eye Institute Omaha Nebraska 68105
Sierra Eye Associates Reno Nevada 89502
Mid Atlantic Retina - Wills Eye Hospital Cherry Hill New Jersey 08034
Retinal & Ophthalmic Cons PC Northfield New Jersey 08225
Retina Associates of NJ Teaneck New Jersey 07666
New York Weil Cornell Med Ctr New York New York 10021
Vitreous-Retina-Macula New York New York 10022
Retina Assoc of Western NY Rochester New York 14620
Western Carolina Retinal Associate PA Asheville North Carolina 28803
Char Eye Ear &Throat Assoc Charlotte North Carolina 28210
Duke University Eye Center; Vitreoretinal Durham North Carolina 27710
Cincinnati Eye Institute Cincinnati Ohio 45242
OSU Eye Physicians & Surgeons Columbus Ohio 43212
Retina & Vitreous Center of Southern Oregon Ashland Oregon 97520
Retina Northwest Portland Oregon 97221
Oregon HSU; Casey Eye Institute Portland Oregon 97239
Mid Atlantic Retina Philadelphia Pennsylvania 19107
Allegheny Ophthalmic & Orbital Pittsburgh Pennsylvania 15212
MUSC Storm eye institute Charleston South Carolina
Palmetto Retina Center Florence South Carolina 29501
Charleston Neuroscience Inst Ladson South Carolina 29456
Black Hills Eye Institute Rapid City South Dakota 57701
Southeastern Retina Associates Chattanooga Chattanooga Tennessee 37421
Charles Retina Institution Germantown Tennessee 38138
Retina Res Institute of Texas Abilene Texas 79606
Texas Retina Associates Dallas Texas 75231
Retina Consultants of Houston Houston Texas 77030
Scott and White Hospital Temple Texas 76504
Retina Consultants of Houston The Woodlands Texas 77384
Univ of Virginia Ophthalmology Charlottesville Virginia 22903
Vitreoretinal Associates of Washington Bellevue Washington 98004

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 86 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02247531, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 14, 2019 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02247531 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →